Europe Digital Biomarkers Market

Europe Digital Biomarkers Market size was valued at USD 1.3 billion in 2025 and is forecast to grow from USD 1.6 billion in 2026 to reach USD 3.8 billion by 2031, at a CAGR of 23.7%.

Description

The Europe Digital Biomarkers Market size was valued at USD 1.3 billion in 2025 and is forecast to grow from USD 1.6 billion in 2026 to reach USD 3.8 billion by 2031, at a CAGR of 23.7%. Digital biomarkers are objective, quantifiable physiological and behavioral data collected and measured by digital devices, such as wearables, implantables, and mobile applications, to explain, influence, or predict health-related outcomes. Unlike static lab-based biomarkers, digital biomarkers enable continuous, real-time observation outside traditional healthcare settings, positioning the technology as a regulated component of clinical development and remote-care delivery across the region. The market sits at the intersection of digital health, wearable-sensor engineering, and clinical-research innovation, making it one of the most closely watched enabling technologies across the regional healthcare-data value chain.

Demand for digital biomarker platforms remains anchored by the accelerating integration of digital endpoints into regulatory science, rising adoption of remote patient monitoring technologies, and increasing demand for continuous real-world health data in clinical development across Germany, the United Kingdom, France, and Italy. Beyond clinical trials, digital biomarkers continue to enable applications in chronic-disease management, early diagnosis, and drug-development research that require precise, continuous physiological and behavioral data capture. Rising adoption of wearable devices, mobile health applications, and AI-driven analytics, alongside the emergence of digital therapeutics with embedded biomarker capabilities, are sustaining consumption even as the region's digital-health infrastructure continues to mature.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • Europe Digital Biomarkers Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type (Wearable Biomarkers, Mobile-based Biomarkers, Sensor-based Biomarkers, Software-based Biomarkers, Others)

      2. By Application (Clinical Trials, Remote Patient Monitoring, Disease Management, Drug Development, Others)

      3. By End User (Pharmaceutical & Biotechnology Companies, Healthcare Providers, Research Institutes, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • Germany Digital Biomarkers Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type

      2. By Application

      3. By End User

  • United Kingdom Digital Biomarkers Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type

      2. By Application

      3. By End User

  • France Digital Biomarkers Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type

      2. By Application

      3. By End User

  • Rest of Europe Digital Biomarkers Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • Europe Digital Biomarkers Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. IXICO plc

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. AliveCor, Inc.

    3. Evidation Health, Inc.

    4. Altoida, Inc.

    5. Koneksa Health, Inc.

    6. Biofourmis, Inc.

    7. Huma Therapeutics Limited

    8. VivoSense, Inc.

    9. Click Therapeutics, Inc.

    10. Kaia Health Software GmbH

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology